EUVIMEDEUVIMED entdecken
EditorialKommentarOpen Access

An itch finally addressed: linerixibat and the promise of targeted antipruritic therapy in primary biliary cholangitis

Elizabeth E Williams iD, Raj Vuppalanchi iD

Translational Gastroenterology and Hepatology · 2026-07 · 11 · 79-79

DOI: 10.21037/tgh-2026-0052 ↗

Kurz gefasst

Editorial in der Zeitschrift Translational Gastroenterology and Hepatology, 2026-07. Verfasst von Elizabeth E Williams und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, USA. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Linerixibatprimary biliary cholangitis (PBC)pruritus

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, USA.

ORCID-Profile: Elizabeth E Williams, Raj Vuppalanchi

Zitieren

APA

Williams, E. E., & Vuppalanchi, R. (2026). An itch finally addressed: linerixibat and the promise of targeted antipruritic therapy in primary biliary cholangitis. Translational Gastroenterology and Hepatology, 11, 79-79. https://doi.org/10.21037/tgh-2026-0052

Vancouver

Williams EE, Vuppalanchi R. An itch finally addressed: linerixibat and the promise of targeted antipruritic therapy in primary biliary cholangitis. Translational Gastroenterology and Hepatology. 2026;11:79-79. doi:10.21037/tgh-2026-0052

BibTeX
@article{Williams2026,
  author = {Williams, Elizabeth E and Vuppalanchi, Raj},
  title = {An itch finally addressed: linerixibat and the promise of targeted antipruritic therapy in primary biliary cholangitis},
  journal = {Translational Gastroenterology and Hepatology},
  year = {2026},
  volume = {11},
  pages = {79--79},
  doi = {10.21037/tgh-2026-0052}
}
Kostenlos starten →